Open AccessSafety of hydroxychloroquine in healthcare workers for COVID-19 prophylaxis
Author(s) -
Atiya Faruqui,
Denis Xavier,
S. R. Kamat,
Sujith J Chandy,
Bikash Medhi,
Raakhi K Tripathi,
Yashashri C Shetty,
John Michael Raj,
Sandeep Kaushal,
Shibu Balakrishnan,
Shubham Atal,
Santanu Kumar Tripathi,
Dinesh Badyal,
Harihar Dikshit,
Sukalyan Saha Roy,
Niyati Trivedi,
Suparna Chatterjee,
Chetna Desai,
Chandramauli Tripathi,
Nirmala N Rege,
Pooja Gupta,
Reena Raveendran,
Rajni Kaul,
Nilima A Kshirsagar
Publication year - 2021
Publication title -
indian journal of medical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.578
H-Index - 87
ISSN - 0971-5916
DOI - 10.4103/ijmr.ijmr_2294_20
Subject(s) - hydroxychloroquine , covid-19 , medicine , pre exposure prophylaxis , virology , health care , intensive care medicine , human immunodeficiency virus (hiv) , outbreak , disease , infectious disease (medical specialty) , syphilis , men who have sex with men , economics , economic growth
Hydroxychloroquine (HCQ), reported to inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in in vitro studies, has been recommended for prophylaxis of COVID-19 in healthcare workers (HCWs). The objective of this study was to assess short-term adverse events (AEs) of HCQ in HCWs.